Stanford researchers have developed an exceptionally fast, sensitive, and compact X-ray imaging system for distinguishing liquids and other materials in aviation security applications.
Hydrogen is becoming increasingly important as a clean energy fuel source. Accurate measurement of hydrogen concentration is essential, as it impacts fuel pricing and ensures safety during production, refinement, and transportation.
CT imaging and MR imaging are two essential and widely used techniques for diagnostics. Currently, the two imaging techniques are performed sequentially, which is time-consuming and prone to errors due to anatomical changes that occur between the scans.
Researchers at Stanford and WashU developed cannabinoid receptor agonists with distribution mainly to peripheral tissues. Cannabinoid agonists are relevant for treatment of many indications, but current clinical use is limited by a variety of side effects.
Stanford researchers have developed a machine learning-based application that standardizes patient radiology reporting in a local and secure manner and outperforms all other general large language models (LLMs).
Stanford researchers have developed innovative ophthalmic compounds that temporarily or permanently clear opacities in ocular tissues such as the cornea, lens, and sclera.
Aging-associated mitochondrial dysfunction (mito-dysfunction) affects every cell system in our body. Mito-dysfunction includes reduced quality of mitochondrial DNA (mtDNA), irregular generation of reactive oxygen species, and membrane potential.
Complementary metal-oxide-semiconductor (CMOS) is critical semiconductor technology that utilizes both n-type and p-type field-effect transistors (FETs).
Stanford researchers have developed SAGE, an AI-powered drug discovery platform that designs novel drug molecules directly within a target protein's binding pocket in 3D space, accelerating the identification of promising drug candidates.
Stanford researchers in the KC Huang Lab have patented a method that identifies functionally conserved protein regions with recurrent genomic alterations in cohort studies using natural variations in genomic sequences, which allows for the discovery and further understanding o
In light of the opioid epidemic within the United States, Dr. Eric Gross and colleagues developed a non-opioid therapeutic that reduces pain (Stanford Medicine Press Release).
Stanford researchers have developed novel ENPP1 and ENPP3 inhibitors for cancer immunotherapy. ENPP1 inhibitors have previously been reported but ENPP3 is a newly discovered target.
3D models and textures for 45% of the human male. 3D models of Rodin hand sculptures. Patient education iBook content and template. Anatomy Viewer codebase.
Stanford researchers have engineered a human protease that reduces instances of unintended protein interactions with the human proteome and mitigates immunogenic risks associated with synthetic biology tools made from bacteria and viruses.